Related Experiment Video
Updated: May 18, 2026
08:22
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
[A flow cytometric postmortem brain study for major depressive disorders: implication for oligodendroglial
Yoshitaka Hayashi1, Yoshitaka Tatebayashi
1Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|September 28, 2012
Summary
Major depressive disorder (MDD) shows reduced oligodendrocyte precursor cells in the frontopolar cortex, suggesting myelination abnormalities contribute to MDD pathogenesis. This finding utilizes a novel flow cytometry method for brain tissue analysis.
Area of Science:
- Neuroscience
- Psychiatry
- Cell Biology
Context:
- Neuropathology of psychiatric disorders is crucial for understanding disease mechanisms.
- Major depressive disorder (MDD) is associated with prefrontal cortex abnormalities.
- Previous quantitative studies are limited by low-throughput stereological techniques.
Purpose:
- To develop and apply a novel, high-throughput flow cytometry method for quantitative analysis of postmortem brain tissue.
- To investigate cellular differences in the frontopolar and inferior temporal cortex of MDD patients compared to controls.
Summary:
- A new flow cytometry technique was used to analyze nuclei from frozen, unfixed postmortem brain tissue.
- Quantification of DNA (7-AAD), neuronal (NeuN), and oligodendroglial (olig2) markers revealed significantly reduced 7-AAD(+) and olig2(+) nuclei densities in the frontopolar cortex of MDD subjects.
- No significant differences were observed in the inferior temporal cortex.
Impact:
- Findings suggest that abnormalities in cortical myelination in the adult frontopolar cortex may be involved in the pathogenesis of MDD.
- The developed flow cytometry method offers a faster, more efficient approach for neuropathological studies.
- This research opens new avenues for understanding the biological underpinnings of major depressive disorder.
